Preclinical evaluation of AFM24, a novel CD16A-specific innate immune cell engager targeting EGFR-positive tumors

por Wingert, Susanne, Reusch, Uwe, Knackmuss, Stefan, Kluge, Michael, Damrat, Michael, Pahl, Jens, Schniegler-Mattox, Ute, Mueller, Thomas, Fucek, Ivica, Ellwanger, Kristina, Tesar, Michael, Haneke, Torsten, Koch, Joachim, Treder, Martin, Fischer, Wolfgang, Rajkovic, Erich
Publicado 2021